Morgan Stanley Call 60 INCY 20.12.../ DE000ME9H2Y1 /
5/10/2024 8:08:17 PM | Chg.-0.08 | Bid10:00:35 PM | Ask10:00:35 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.38EUR | -5.48% | - Bid Size: - |
- Ask Size: - |
Incyte Corporation | 60.00 USD | 12/20/2024 | Call |
GlobeNewswire
5/9
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire
5/8
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
4/2
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire
4/1
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire
2/28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
1/9
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
12/9/2023
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire
11/16/2023
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire
11/2/2023
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire
10/23/2023
Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
GlobeNewswire
8/28/2023
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
GlobeNewswire
3/23/2022
RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...
GlobeNewswire
3/14/2022
STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
GlobeNewswire
3/1/2022
Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus R...
GlobeNewswire
2/28/2022
Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Up...
GlobeNewswire
2/24/2022
MacroGenics Provides Update on Corporate Progress and 2021 Financial Results